{"filing":{"accession_number":"0001193125-26-237150","cik":"0001544227","ticker":"TPST","company_name":"Tempest Therapeutics, Inc.","form":"8-K","filing_date":"2026-05-22","report_date":null,"primary_document":"d29824d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1544227/000119312526237150/d29824d8k.htm"},"events":[{"id":10589,"run_id":9289,"accession_number":"0001193125-26-237150","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Three board members—Stephen Brady, Michael Raab, and Christine Pellizzari—resigned from the Board of Directors effective May 22, 2026. The filing explicitly states these resignations were not due to disagreement with the Company. The simultaneous departure of three directors is a material event affecting board composition and governance, and would affect a reasonable investor's assessment of the registrant's leadership and stability.","company_name":"Tempest Therapeutics, Inc.","ticker":"TPST","filing_date":"2026-05-22","form":"8-K","submitted_at":null,"items":[{"id":6936,"accession_number":"0001193125-26-237150","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Three board members—Stephen Brady, Michael Raab, and Christine Pellizzari—resigned from the Board of Directors effective May 22, 2026. The filing explicitly states these resignations were not due to disagreement with the Company. The simultaneous departure of three directors is a material event affecting board composition and governance, and would affect a reasonable investor's assessment of the registrant's leadership and stability.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:29:38.388717+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6936,"accession_number":"0001193125-26-237150","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Three board members—Stephen Brady, Michael Raab, and Christine Pellizzari—resigned from the Board of Directors effective May 22, 2026. The filing explicitly states these resignations were not due to disagreement with the Company. The simultaneous departure of three directors is a material event affecting board composition and governance, and would affect a reasonable investor's assessment of the registrant's leadership and stability.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:29:38.388717+00:00","company_name":"Tempest Therapeutics, Inc.","ticker":"TPST","filing_date":"2026-05-22"}]}